GAMMA Investing LLC Purchases 33,541 Shares of Sotera Health Company (NASDAQ:SHC)

GAMMA Investing LLC increased its position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 816.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 37,650 shares of the company's stock after acquiring an additional 33,541 shares during the period. GAMMA Investing LLC's holdings in Sotera Health were worth $439,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of SHC. Empowered Funds LLC bought a new stake in shares of Sotera Health during the fourth quarter worth about $351,000. New York State Teachers Retirement System raised its stake in shares of Sotera Health by 8.7% during the fourth quarter. New York State Teachers Retirement System now owns 58,173 shares of the company's stock valued at $796,000 after acquiring an additional 4,673 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Sotera Health by 504.0% during the fourth quarter. Blue Trust Inc. now owns 4,192 shares of the company's stock valued at $57,000 after acquiring an additional 3,498 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Sotera Health by 3.8% during the fourth quarter. Rhumbline Advisers now owns 399,171 shares of the company's stock worth $5,461,000 after purchasing an additional 14,616 shares during the period. Finally, State of New Jersey Common Pension Fund D grew its stake in shares of Sotera Health by 21.5% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 154,237 shares of the company's stock worth $2,110,000 after purchasing an additional 27,247 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Performance

Shares of Sotera Health stock traded up $0.45 during mid-day trading on Friday, hitting $11.39. 1,674,019 shares of the stock were exchanged, compared to its average volume of 1,233,498. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.08. The company has a 50-day simple moving average of $11.91 and a 200 day simple moving average of $12.46. The company has a market capitalization of $3.23 billion, a P/E ratio of 142.39 and a beta of 1.87. The company has a debt-to-equity ratio of 5.55, a quick ratio of 2.19 and a current ratio of 2.46.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02. The company had revenue of $254.52 million during the quarter, compared to analyst estimates of $245.56 million. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.13 earnings per share. Sell-side analysts anticipate that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on SHC shares. The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $14.00 to $17.00 in a research note on Monday, May 5th. Wall Street Zen downgraded shares of Sotera Health from a "buy" rating to a "hold" rating in a research note on Saturday, June 7th. Barclays lowered their target price on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Finally, Piper Sandler dropped their price target on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $15.80.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.